Dhanya Bio Life Sciences: Strengthening Animal Nutrition through Science & Manufacturing Excellence

Seelam Madhu Babu, Managing Director

Seelam Madhu Babu

Managing Director

As livestock and poultry producers pursue better pro­ductivity, animal health and feed efficiency, feed supple­ments are becoming an increasingly important part of modern farm management. The opportunity for manufacturers lies not merely in supplying products, but in developing formu­lations that combine nutritional effectiveness with consistency, quality control and dependable technical support.

At the same time, strengthening domestic manufacturing can reduce de­pendence on imported products while giving customers great­er access to manufacturers and their technical capabilities.

Dhanya Bio Life Sciences is positioning itself within this space as a Hyderabad-based manufacturer and exporter of feed supplements and probiotic and prebiotic solutions for poultry, cattle and aqua applications. Established in 2015, the company combines scientific formulation, fermentation capabilities, laboratory infrastructure, manufacturing scale and field-oriented product development.

Its operations are supported by quality systems, including ISO 9001:2015, GMP, FDA Compliance and FAMI-QS, reflecting its emphasis on consistency and compliance. The company today is also moving from predominantly bulk manufacturing towards building a stronger direct market presence.

Driving this journey is Seelam Madhu Babu, whose foundation in science and prior experience with MNCs shaped his approach to manufacturing and R&D. A postgraduate in science who is currently pursuing his PhD, he established the company after gaining industry experience, alongside his wife, Dr. Asha Latha, who has completed her PhD and plays an integral role in the company’s Technical & R&D functions. Together, their scientific backgrounds underpin Dhanya Bio Life Sciences’ emphasis on research-led product development and manufacturing.

Building an Indian Manufacturing Alternative

Dhanya Bio Life Sciences began on a relatively modest scale, operating largely as a bulk manufacturer. For much of its first decade, the company depended on a limited number of market partners rather than developing its own direct presence. While this model enabled it to strengthen manufacturing capabilities, it also meant the Dhanya name remained largely behind the scenes.

“The company is now changing that approach. Having built its production infrastructure, technical team and laboratory capabilities, it is increasingly reaching customers directly and positioning itself as an Indian manufacturing alternative to imported feed-supplement products,” speaks Seelam Madhu Babu, Managing Director.

Its portfolio spans feed supplements, probiotics and prebiotics, with feed supplements accounting for approximately 90 percent of its current manufacturing portfolio. Growth promoters and disease-control products form an important part of this business, while probiotics, prebiotics and other additives constitute the remaining share. Dhanya also has capabilities across powders and granules and works with microbiology- and HPLC-based products.

A key differentiator is its emphasis on developing formulations internally. Rather than depending entirely on imported finished products, its team studies product specifications and market requirements and develops formulations through its own R&D and manufacturing ecosystem.

As a direct manufacturer, Dhanya sees the ability to provide customers with both competitive economics and direct access to technical expertise as an important advantage

Seelam Madhu Babu, Managing Director

Quality from Laboratory to Commercial Scale

For Dhanya, manufacturing scale is closely linked with quality consistency. The company follows a structured scale-up process in which product development can progress from one kilogram to 10 kilograms, then 100 kilograms, one tonne and eventually multi-ton commercial production. Each stage provides an opportunity for the R&D and quality teams to evaluate performance and refine the manufacturing process.

This approach has become particularly important in overcoming one of the company's earliest challenges: market perceptions around domestically manufactured products. According to Madhu, competitively priced Indian products were sometimes perceived as inferior to imported alternatives. Dhanya addressed this not through pricing alone, but by consistently demonstrating product quality over time.

“Quality oversight extends across production, packaging and documentation, with managers and supervisors monitoring operations across shifts. The company also encourages transparency with customers. In the event of a quality concern, it is prepared to undertake joint analysis and allow customers to engage directly with its laboratory and technical teams,” shares Seelam Madhu Babu.

Its Hyderabad facility further brings together production equipment, fermentation expertise, laboratory infrastructure and skilled personnel across R&D, quality and manufacturing. The company's own website similarly identifies scientific formulation, strict quality control, field performance and technical support as central to its operating approach.

Turning Market Intelligence into Product Development

Animal nutrition is not static, and Dhanya's product-development approach therefore extends beyond the manufacturing floor. Its team maintains interactions with doctors, animal nutritionists and other industry professionals to understand new formulations, evolving requirements and products emerging in domestic and international markets.

When a relevant opportunity is identified, the R&D team studies specifications and works towards developing a comparable or improved solution. Raw-material selection, testing methodologies and formulation processes are treated as important variables rather than assuming that common manufacturing technology will produce identical outcomes.

This technical orientation is complemented by customer support across quality verification, production, packaging and documentation. As a direct manufacturer, Dhanya sees the ability to provide customers with both competitive economics and direct access to technical expertise as an important advantage.

Taking Dhanya from Bulk Manufacturing to a Global Market

The next phase represents a significant transition for Dhanya Bio Life Sciences. After spending much of the past decade primarily serving the market as a bulk manufacturer, the company is now investing greater attention in direct marketing and building stronger visibility for the Dhanya brand.

“Over the next four to five years, it plans to expand its existing manufacturing facility, increase production volumes and strengthen its reach across India as well as international markets. Product development will continue alongside this expansion, supported by the company's R&D, fermentation, laboratory and production capabilities,” informs Seelam Madhu Babu.

Madhu's larger ambition is to establish Dhanya as a strong Indian competitor to major Chinese manufacturers in the feed-supplement space. That aspiration builds on a decade spent developing the less visible but critical foundations of the business—formulation knowledge, manufacturing infrastructure, quality systems and technical manpower.

As Dhanya moves from being predominantly a behind-the-scenes bulk supplier to a more visible market-facing manufacturer, its focus remains straightforward: manufacture at scale without compromising consistency, develop products through science and R&D, and demonstrate that Indian animal-nutrition manufacturing can compete confidently on both quality and value.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.